Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Tuesday, June 22, 2021Arrowhead Pharmaceuticals Inc and Horizon Therapeutics plc today announced a global collaboration and license agreement for AROXDH a previously undisclosed discoverystage investigational RNA interference RNAi therapeutic being developed by Arrowhead...
QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments
Tuesday, June 22, 2021QIAGEN announced the launch of QIAprepamp CRISPR Kit and CRISPR QPrimer Solutions that allow researchers to analyze edited genetic material with unparalleled speed and efficiency to determine how their interventions have changed the function of the D...
Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL.
Monday, June 21, 2021Nanjing Bioheng Biotech Co Ltd Announced UCAR T cell therapy product targeting CD code CTD received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for the treatment of Tcell acute lymphoblastic leukemia TALL CTD is the first...
Biotage Launches New Automated Platform for Plasmid DNA Purification
Monday, June 21, 2021Biotage is pleased to announce the launch of Biotage PhyPrep a new automated platform for plasmid DNA purification that releases laboratory staff from the tedium of repetitive manual labor and takes full advantage of the PhyTip columns dual flow chr...
CytRx Notes Orphazyme’s Regulatory Update from the FDA on Arimoclomol for Niemann-Pick Disease Type C
Saturday, June 19, 2021CytRx Corporation a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories today noted that Orphazyme AS announced it has received a Complete Response Letter CRL from the US...
Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell Therapies
Friday, June 18, 2021Kite a Gilead Company and Shoreline Biosciences Inc Shoreline a biotechnology company developing intelligently designed allogeneic offtheshelf standardized and targeted natural killer NK and Macrophage cellular immunotherapies derived from induced pl...
Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaboration for Eisai’s MORAb-202 Antibody Drug Conjugate
Friday, June 18, 2021Eisai Co Ltd and BristolMyers Squibb Company announced that the companies have entered into an exclusive global strategic collaboration agreement for the codevelopment and cocommercialization of MORAb an antibody drug conjugate ADC MORAb is Eisais fi...
Novartis receives FDA Breakthrough Therapy designation for investigational 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Thursday, June 17, 2021Novartis announced today that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation BTD to LuPSMA an investigational radioligand therapy for the treatment of metastatic castrationresistant prostate cancer mCRPC Breakt...
United Therapeutics Announces FDA Acceptance of Tyvaso DPI™ New Drug Application For Priority Review
Thursday, June 17, 2021United Therapeutics Corporation announced that the US Food and Drug Administration FDA accepted for priority review the New Drug Application NDA for Tyvaso DPI inhaled treprostinil for the treatment of pulmonary arterial hypertension PAH and pulmonar...
Dendreon Pharmaceuticals Invests in Contract Manufacturing and Patient Services for Cell Therapy Partners
Wednesday, June 16, 2021Dendreon Pharmaceuticals a commercialstage biopharmaceutical company and pioneer in the development of cellular immunotherapy has established and invested in its new contract manufacturing and services division to bring latestage clinical assets thro...
